General Information of Drug (ID: DM1GM7N)

Drug Name
PEC-Direct
Indication
Disease Entry ICD 11 Status REF
Type-1 diabetes 5A10 Phase 1/2 [1]
Drug Type
Cell therapy
Cross-matching ID
TTD ID
DK0S5Y

References

1 ClinicalTrials.gov (NCT03163511) An Open-Label, First-In-Human Study Evaluating the Safety, Tolerability, and Efficacy of VC-02? Combination Product in Subjects With Type 1 Diabetes Mellitus and Hypoglycemia Unawareness. U.S.National Institutes of Health.